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Darnell et al., p. 435
The question of how to best approach the issue of second-
ary findings (sometimes also referred to as incidental find-
ings) is familiar to anyone following the rapid develop-
ments taking place in the field of genomic medicine.
In the clinical setting, recommendations from the Amer-
ican College of Medical Genetics suggest that doctors
should actively seek information about discrete classes of
variants. But what about secondary variants uncovered in
a research setting? In this issue, Darnell et al. propose the
establishment of a secondary-genomic-findings service
(SGFS) to standardize the return of clinically actionable
variants to research participants. Through the implemen-
tation of such a service, findings obtained in a research
setting would be, through a standardized process, vali-
dated in a clinical lab and reported to study participants.
Many questions about the proposed SGFS remain; these
include questions about infrastructure, best practices,
cost, and medical implications. The authors do not dis-
count these considerations but rather argue that a discus-
sion of these crucial points is essential for any progress to
be made regarding the manner in which secondary find-
ings are identified, catalogued, and reported.Analyzing Mutually Exclusive Tumor Mutations
Hua et al., p. 442
A primary goal of cancer research is to understandwhich of
the many genetic changes present in a tumor drive growth
and metastasis and which are merely passengers along for
the ride. One strategy for identifying so-called driver muta-
tions is to discern which genes undergo mutation at a rate
higher than the background rate. However, this method
fails to identify infrequently mutated driver genes and
often yields little biological insight. Accordingly, many re-
searchers have begun to search for genes with mutually
exclusive mutational profiles. In this issue, Hua et al.
develop a new method, which they term MEGSA, that is
able to identify mutually exclusive gene sets (MEGS)
through either agnostic or hypothesis-driven frameworks.
The authors identified several MEGS across thirteen cancer
subtypes, including breast cancer, melanoma, and acute
myeloid leukemia (AML). Notably, one of the AML
MEGS, consisting of TP53, NPM1, and RUNX1, is associ-1Deputy Editor, AJHG
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could have some clinical utility. Although this approach
is currently limited to detection of point mutations, future
refinements should enable MEGSA to analyze copy-num-
ber alterations and perhaps even epigenetic changes.ASC-1 Alterations
Knierim et al., p. 473
Co-activator complexes—large,multi-subunit assemblies—
perform diverse cellular functions by integrating intracel-
lular and extracellular signals to fine-tune transcriptional
and metabolic pathways. One such complex, activating
signal cointegrator 1 (ASC-1), is thought to function as a
ribonucleoprotein complex, influencing both gene tran-
scription and RNA processing. In this issue, Knierim et al.
identify mutations in TRIP4 and ASCC1, which encode
two members of the ASC-1 complex, in a disorder typified
by prenatal spinal muscular atrophy and congenital bone
fractures. Zebrafish morphants displayed identical pheno-
types, highlighting the shared cellular functions of these
genes. Moreover, expression profiling revealed changes in
pathways related to neurogenesis and bone development,
providing clues regarding pathomechanism. In uncovering
the genetic cause of a rare disease, the authors also provide
key insights into the cellular function of the ASC-1 macro-
molecular complex. Future experiments should reveal addi-
tional details about ASC-1 and its role in humanhealth and
development.Tracking down TB Resistance
Sobota et al., p. 514
Tuberculosis (TB), a disease caused by infection with
Mycobacterium tuberculosis (MTB), remains a major global
health concern, causing more than one million deaths per
year. AlthoughMTB infections are most prevalent in devel-
opingnations, drug resistance and compromised immunity
withinpopulationshas led to an increase inTB cases around
the globe. Indeed, activeHIV infection greatly increases risk
of progressing from MTB infection to active tuberculosis
disease. Scientists have long suspected a genetic contribu-
tion for susceptibility to MTB infection, but efforts aimed
at exploring this hypothesis have been stymied by issues
surrounding study design and ascertainment. In this
issue, Sobota et al. utilize an extreme study-designy of Human Genetics. All rights reserved.
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approach: assessingMTB infectiononly inAfricanHIV-pos-
itive individuals—all of whom, because of local rates of
infection, are likely to have been exposed toMTB. Through
their analysis, the authors identified a variant in a regulato-
ry region that was located near IL12B and was associated
with resistance to disease, even in cases of latent infection.
Notably, the LD pattern at this locus is conserved across
African populations, a signature of selection. The cause of
this selection is not clear, however, given the role of IL12
in mediating immunity against diverse pathogens. On the
basis of these results, IL12-based therapies might provide
an efficacious method to treat TB across populations.
Running the GAMuT
Broadaway et al., p. 525
The GWAS era yielded several important insights into the
genetic architecture of common diseases and traits. For402 The American Journal of Human Genetics 98, 401–402, March 3instance, it now seems clear that although common vari-
ants collectively explain a large fraction of trait heritability,
the per-variant contribution is quite small. Moreover, indi-
vidual common variants can display pleiotropic features,
influencing multiple, and at times seemingly unrelated,
traits. Now, in this issue, Broadaway et al. explore the feasi-
bility of assessing pleiotropy in studies of rare variants.
Beginning with the supposition that rare variants of large
effect should be highly pleiotropic, the authors develop
a test, which they name Gene Association with Multiple
Traits (GAMuT), that can accommodate analyses of
both binary and continuous phenotypes. Application of
GAMuT to empirical data failed to yield any genome-
wide significant hits; however, several genes’ p values
approached this threshold and might therefore be worthy
of follow-up analysis. The increasing availability of large-
cohort datasets could be exactly what is needed to run
the GAMuT of rare-variant pleiotropy investigations., 2016
